Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix— 510(k) K240424

Name: FDA 510(k) clearance K240424
Creator: U.S. Food and Drug Administration
Published: 2024-03-12

Substantially Equivalent

Collagen Matrix, Inc.

FDA 510(k) clearance K240424 for Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix, Substantially Equivalent on 2024-03-12. Applicant: Collagen Matrix, Inc.. Device class: 2.

Clearance details

Applicant: Collagen Matrix, Inc.
Product code: Code MQV
Device class: Class 2
Regulation: 21 CFR 888.3045
Advisory panel: Orthopedic
Date received: 2024-02-13
Decision date: 2024-03-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Oakland, NJ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MQV

view all

K262230 — Mg OSTEOREVIVE; Mg OSTEOCRETE2026-09-11
K260364 — Device 300419 Strip2026-06-02
K252797 — JAZBI Resorbable Bone Void Filler2026-05-26
K261008 — Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more2026-04-24
K253524 — Adaptos®Fuse Bone Graft2026-02-17

More clearances from Collagen Matrix, Inc.

view all

K251191 — Collagen Dura Regeneration Membrane - Repair2025-11-18
K243071 — Bovine Dermis Collagen Dermal Matrix2024-12-19
K242302 — RejuvaKnee Collagen Meniscus Implant2024-10-02
K233203 — Soft Tissue Augmentation Resorbable Matrix2024-05-01
K231942 — Mineral Collagen Composite Bioactive Extra Moldable2023-08-02

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.